ARCHIVES

Clinical Trials Approved By NCI

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

Recombinant Protein C Cuts Risk Of Sepsis Death

February 22, 2002

Exercise Improves Function, Symptoms Of Cancer Survivors, AHRQ Report Finds

August 27, 2004

In Brief: “…In Case Mrs. Lasker Happens To See A Senator”; White Potter Defend Center Progress

June 16, 1978

In Brief: Fidler Wins BMS Cancer Research Award; Thomas Cech To Head Howard Hughs Inst.

April 2, 1999

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

September 13, 2002